How do you pay?

How to pay the least

Ask for the cash price

Litfulo

We didn’t find one.

  1. Ask your pharmacy for Litfulo’s cash price, and one or two other pharmacies too.
  2. Litfulo’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Pfizer Patient Assistance Program. Meet the income requirements – Your annual household pre-tax income cannot exceed 300% of the Federal Poverty Level, adjusted for household size. Or call 1-844-989-7284.

See if you qualify 

Compare every option

Question
Brand nameLitfulo
Authorized genericritlecitinib
Regular genericritlecitinib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Litfulo?
The original
–
–

Brand nameThe maker’s card

Pfizer Dermatology Patient Access Copay Savings Card

Savings card from Pfizer

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $4,000–$15,000 a year off your co-pay.

Sign up on litfulo.com 

Or call 1-833-956-3376.

In the maker’s words

“By using this copay card at participating pharmacies, eligible patients with commercial prescription drug insurance coverage for LITFULO® (ritlecitinib) may pay as little as $0 per month.”

From the maker’s offer on litfulo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Litfulo itself, from the same company, sold without the brand name, and usually for less. For now Litfulo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.

Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.

Source: the FDA label for Litfulo (U.S. Pharmaceuticals), June 17, 2026. Full label on DailyMed 

Good to know